Strong induction of activin expression after injury suggests an important role of activin in wound repair

Developmental Biology

Volumn 173, Issue 2, 1996, Pages 490-498

  Hübner, Griseldis ^a   Qianjin, Hu ^b   Smola, Hans ^c   Werner, Sabine ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Klin fur Dermatol und Venerologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; MYELOPID; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; WOUND HEALING;

EID: 0342902626     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1996.0042     Document Type: Article

References (49)

1. Albano, R. M., Groome, N., and Smith, J. C. (1993). Activins are expressed in preimplantation mouse embryo and in ES and EC cells and are regulated on their differentiation. Development 117, 711-723.
2. Albano, R. M., Arkell, R., Beddington, R. S. P., and Smith, J. C. (1994). Expression of inhibin subunits and follistatin during postimplantation mouse development; decidual expression of activin and expression of follistatin in primitive streak, somites and hindbrain. Development 120, 803-813.
3. Attisano, L., Wrana, J. L., Cheifetz, S., and Massague, J. (1992). Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68, 97-108.
4. Attisano, L., Carcamo, J., Ventura, F., Weis, F. M. B., Massague, J., and Wrana, J. L. (1993). Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671-680.
5. Baird, A., and Durkin, T. (1986). Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factors. Biochem. Biophys. Res. Commun. 138, 476-482.
6. Carcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., and Massague, J. (1994). Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14, 3810-3821.
7. Choi, Y., and Fuchs, E. (1990). TGF-beta and retinoic acid: Regulators of cell growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1, 791-809.
8. Esch, F. S., Shimasaki, S., Mercado, M., Cooksey, K., Ling, N., Ying, S., Ueno, N., and Guilleman, R. (1987). Structural characterization of follistatin: A novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol. Endocrinol. 1, 849-855.
9. Feijen, A., Goumans, M. J., and van den Eijnden-van Raaij, A. J. M. (1994). Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins. Development 120, 3621-3637.
10. Eto, Y., Tsuji, T., Takezawa, S., Takano, T., Yokogawa, Y., and Shibai, H. (1987). Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line, THP-1. Biochem. Biophys. Res. Commum. 142, 1095-1103.
11. Frater-Schröder, M., Muller, G., Birchmeier, W., and Böhlen, P. (1986). Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun. 137, 295-302.
12. Hashimoto, M., Kondo, S., Sakurai, T., Eto, Y., Shibai, H., and Muramatsu, M. (1990). Activin/EDF as an inhibitor of neural differentiation. Biochem. Biophys. Res. Commun. 173, 193-200.
13. Hebda, P. A. (1988). Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J. Invest. Dermatol. 91, 440-445.
14. Levine, J. H., Moses, H. L., Gold, L. I., and Nanney, L. B. (1993). Spatial and temporal patterns of immunoreactive TGFβ1, β2, β3 during excisional wound repair. Am. J. Pathol. 143, 368-380.
15. Lyons, K. M., Jones, C. M., and Hogan, B. L. M. (1991). The DVR gene family in embryonic development. Trends Genet. 7, 408-412.
16. Mansbridge, J. N., and Hanawalt, P. C. (1988). Role of transforming growth factor beta in the maturation of human epidermal keratinocytes. J. Invest. Dermatol. 90, 336-341.
17. Massague, J. (1990). The transforming growth factor-β family. Ann. Rev. Cell. Biochem. 6, 597-641.
18. Mathews, L. S., and Vale, W. W. (1991). Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65, 973-982.
19. Mathews, L. S., and Vale, W. W. (1993). Molecular and functional characterization of activin receptors. Receptor 3, 173-181.
20. Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., and Bradley, A. (1992). α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360, 313-319.
21. Matzuk, M. M., Finegold, M. J., Mather, J. P., Krummen, L., Lu. H., and Bradley, A. (1994). Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. USA 91, 8817-8821.
22. Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., and Bradley, A. (1995a). Functional analysis of activins during mammalian development. Nature 274, 354-356.
23. Matzuk, M. M., Lu, N., Vogel, H., Sellheyer, K., Roop, D. R., and Bradley, A. (1995b). Multiple defects and perinatal death in mice deficient in follistatin. Nature 374, 360-363.
24. Mayo, K. E. (1994). Inhibin and activin: Molecular aspects of regulation and function. TEM 5, 407-415.
25. Michel, U., Farnworth, P., and Findlay, J. K. (1993). Follistatins: More than follicle-stimulating hormone suppressing proteins. Mol. Cell. Endocrinol. 91, 1-11.
26. Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., and Sugino, H. (1990). Activin-binding protein from rat ovary is follistatin. Science 247, 836-838.
27. Nishimura, M., Kaku, K., Azuno, Y., Okafuji, K., Eto, Y., Shiozaki, M., Sasaki, H., Inoue, T., and Kaneko, T. (1991). Effect of erythroid differentiation factor on megakaryocytic differentiation of L8057, a murine megakaryoblastic leukemia cell line. Biochem. Biophys. Res. Commun. 181, 1042-1047.
28. Pittelkow, M., Coffey, R., and Moses, H.L. (1988). Keratinocytes produce and are regulated by transforming growth factors. Ann. N.Y. Acad. Sci. 548, 211-224.
29. Pittelkow, M. R., Coffey, R. J., and Moses, H. L. (1991). Transforming growth factor-β and other growth factors. In "Physiology, Biochemistry and Molecular Biology of the Skin" (L. A. Goldsmith, Ed.), pp. 351-384. Oxford Univ. Press.
30. Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., Kehrl, J. H., and Fauci, A. S. (1986). Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171.
31. Roberts, V. J., Sawchenko, P. E., and Vale, W. (1991). Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 128, 3122-3129.
32. Roberts, V. J., and Barth, S. L. (1994). Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid-and late-gestation rat embryogenesis. Endocrinology 134, 914-923.
33. B are viable and fertile. Mech. Devel. 47, 43-51.
34. Schubert, D., Kimura, H., LaCorbiere, M., Vaughan, J., Karr, D., and Fischer, W. H. (1990). Activin is a nerve cell survival molecule. Nature 344, 868-870.
35. Sellheyer, K., Bickenbach, J. R., Rothnagel, J. A., Bundman, D., Longley, M. A., Krieg, T., Roche, N. S., Roberts, A. B., and Roop, D. R. (1993). Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA 90, 5237-5241.
36. Shah, M., Foreman, D. M., and Ferguson, M. W. J. (1995). Neutralization of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108, 985-1002.
37. Shipley, G. D., Pittelkow, M. R., Wille, J. J., Scott, R. E., and Moses, H. L. (1986). Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor -growth inhibitor in serum free medium. Cancer Res. 46, 2068-2071.
38. Smith, J. C., Price, B. M. J., van Nimmen, K., and Huylebroeck, D. (1990). Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345, 729-731.
39. ten Dijke, P., Ichijo, H., Franzen, P., Schulz, P., Saras, J., Toyoshima, H., Heldin, C.-H., and Miyazono, K. (1993). Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8, 2879-2887.
40. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C.-H. (1994). Characterization of type I receptors for transforming growth factor-β and activin. Science 264, 101-104.
41. Thomson, G., Woolf, T., Whitman, M., Sokoi, S., Vaughan, J., Vale, W., and Melton, D.A. (1990). Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63, 485-493.
42. Vale, W., Hsueh, A., Rivier, C., and Yu, J. (1990). The inhibin/ activin family of hormones and growth factors. In "Peptide Growth Factors and Their Receptors II (M. B. Sporn and A. B. Roberts, Eds.), pp. 211-248. Springer-Verlag.
43. van den Eijnden - van Raaij A. J. M., van Zoelen, E. J. J., van Nimmen, K., Koster, C. H., Snoek, G. T., Durston, A. J., and Huylebroeck, D. (1990). Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction. Nature 345, 732-735.
44. B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8, 414-427.
45. Verschueren, K., Dewulf, N., Goumans, M.-J., Lonnoy, O., Feijen, A., Grimsby, S., Vande Spiegle, K., ten Dijke, P., Moren, A., Vanscheeuwijck, P., Heldin, C.-H., Miyazono, K., Mummery, C., van den Eijnden-van Raaij, J., and Huylebroeck, D. (1995). Expression of type land type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech. Dev. 52, 109-123.
46. Werner, S., Peters, K. G., Longaker, M. T., Fuller-Pace, F., Banda, M. J., and Williams, L. T. (1992). Large induction of keratinocyte growth factor expression in the dermis after injury. Proc. Natl. Acad. Sci. USA 89, 6896-6990.
47. Werner, S., Weinberg, W., Liao, X., Peters, K. G., Blessing, M., Yuspa, S. H., Weiner, R., and Williams, L. T. (1993). Targeted expression of a dominant-negtive FGF receptor mutant in the epidermis oftransgenic mice reveals arole of FGF in keratinocyte organization and differentiation. EMBO J. 12, 2635-2643.
48. Wilkinson, D., Bailes, J., Champion, J., and McMahon, A. (1987). A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development 99, 493-500.
49. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGFβ receptor. Nature 370, 341-347.